Literature DB >> 15503142

Haplotype block and superblock structures of the alpha1-adrenergic receptor genes reveal echoes from the chromosomal past.

B Buzas1, I Belfer, H Hipp, I Lorincz, C Evans, G Phillips, J Taubman, M B Max, D Goldman.   

Abstract

A significant proportion of the human genome is contained within haplotype blocks across which pairwise linkage disequilibrium (LD) is very high. However, LD is also often high between markers at more remote distances, and within different haplotype blocks. Here, we evaluate the origins of haplotype block structure in the three genes for alpha1 adrenergic receptors (alpha1-AR) in the human genome ( ADRA1A, ADRA1B and ADRA1D) by genotyping dense single-nucleotide polymorphism (SNP) marker maps, and show that LD signals between distant markers are due to the presence of extended haplotype superblocks in individuals with ancient chromosomes which have escaped historic recombination. ARs mediate the physiological effects of epinephrine and norepinephrine, and are targets of many therapeutic drugs. This work has identified haplotype backgrounds of alpha1-AR missense variants, haplotype block structures in US Caucasians and African Americans, and haplotype tag SNPs for each block, and we present strong evidence for ancient haplotype block superstructure at these genes which has been partially disrupted by recombination, and evidence for reinstatement of linkage disequilibrium by subsequent recombination events. ADRA1A is comprised of four haplotype blocks in US Caucasians, while in African Americans Block 1 is split. ADRA1B has four blocks in US Caucasians, but in African Americans only the first two blocks are present. ADRA1D has two blocks in US Caucasians, and the first block is replaced by two smaller blocks in African Americans. For both ADRA1A and ADRA1B, haplotype superstructures may represent a novel, higher-level hierarchy in the human genome, which may reduce redundancy of testing by further aggregation of genotype data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503142     DOI: 10.1007/s00438-004-1074-9

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  27 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Activation of signal transducers and activators of transcription by alpha(1A)-adrenergic receptor stimulation in PC12 cells.

Authors:  H Zhong; T J Murphy; K P Minneman
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

3.  Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy.

Authors:  M J Zuscik; S Sands; S A Ross; D J Waugh; R J Gaivin; D Morilak; D M Perez
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

4.  A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease.

Authors:  C J Hong; Y C Wang; T Y Liu; H C Liu; S J Tsai
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

5.  The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy.

Authors:  M T Ramirez; V P Sah; X L Zhao; J J Hunter; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

6.  Systemic overexpression of the alpha 1B-adrenergic receptor in mice: an animal model of epilepsy.

Authors:  Takeharu Kunieda; Michael J Zuscik; Atthaporn Boongird; Dianne M Perez; Hans O Lüders; Imad M Najm
Journal:  Epilepsia       Date:  2002-11       Impact factor: 5.864

7.  Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: inhibition by protein kinase A.

Authors:  Y Ruan; H Kan; J H Parmentier; S Fatima; L F Allen; K U Malik
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

8.  Allelic variants of the alpha1a adrenoceptor and the promoter region of the alpha2a adrenoceptor and temperament factors.

Authors:  S J Tsai; Y C Wang; C J Hong
Journal:  Am J Med Genet       Date:  2001-01-08

9.  Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.

Authors:  R Büscher; V Herrmann; K M Ring; M T Kailasam; D T O'Connor; R J Parmer; P A Insel
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

10.  Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells.

Authors:  M Xing; P A Insel
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

View more
  5 in total

1.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

2.  GABRG1 and GABRA2 as independent predictors for alcoholism in two populations.

Authors:  Mary-Anne Enoch; Colin A Hodgkinson; Qiaoping Yuan; Bernard Albaugh; Matti Virkkunen; David Goldman
Journal:  Neuropsychopharmacology       Date:  2008-09-24       Impact factor: 7.853

3.  Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.

Authors:  Viviana Romero; Charles E Larsen; Jonathan S Duke-Cohan; Edward A Fox; Tatiana Romero; Olga P Clavijo; Dolores A Fici; Zaheed Husain; Ingrid Almeciga; Dennis R Alford; Zuheir L Awdeh; Joaquin Zuñiga; Lama El-Dahdah; Chester A Alper; Edmond J Yunis
Journal:  BMC Genet       Date:  2007-04-12       Impact factor: 2.797

4.  Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.

Authors:  A Adefurin; L V Ghimire; U Kohli; M Muszkat; G G Sofowora; C Li; S Y Paranjape; C M Stein; D Kurnik
Journal:  Pharmacogenomics J       Date:  2014-11-25       Impact factor: 3.550

5.  Genetic variation in the alpha1B-adrenergic receptor and vascular response.

Authors:  A Adefurin; L V Ghimire; U Kohli; M Muszkat; G G Sofowora; C Li; R T Levinson; S Y Paranjape; C M Stein; D Kurnik
Journal:  Pharmacogenomics J       Date:  2016-04-19       Impact factor: 3.550

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.